Radiant Biotherapeutics Announces Poster Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A copy of each poster presentation is available on the Scientific Resources page of the Repare Therapeutics website and a copy of each mini-oral presentation will be available on the Scientific ...

Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical models Anti-IL1RAP ADC targets ...

The US Food and Drug Administration on Wednesday approved a cancer drug developed by China-based Akeso Inc, marking a ...

Sheikha Shamsa bint Hasher Al Maktoum, General Supervisor of Women's Sports at Al Wasl Club, inaugurated the fourth edition of Middle Eastern Alliance for Parenteral and Enteral Nutrition Congress ...

CatalYm today announced the presentation of the first preclinical data demonstrating that the company's clinical-stage antibody visugromab can improve the anti-tumor activity of antibody-drug ...

The Magical universe of #TheLibrarians is about to expand in "The Next Chapter" with a two night season premiere starting May 25th on @tntdrama! Return to the wonder or discover it for the first time!

"One of the most ridiculous things I've seen in a second hand shop." Shopper baffled after spotting absurdly overpriced item ...

Researchers are just beginning to understand how microplastics might be affecting human health. A Reporter visited a lab to ...

EQS-News: Pentixapharm Holding AG / Key word (s): Conference/Scientific publication Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 ...

This great global congress looks forward to addressing all fundamental, clinical, epidemiological and social aspects of ...